Article PDF
Use our pre-submission checklist
Avoid common mistakes on your manuscript.
References
Bartlett RR, Dimitrijevic M, Mattar T, et al. Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection. Agents and Actions 1991; 32: 10–21
Mladenovic V, Domljan Z, Rozman B, et al. Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Arthritis and Rheumatism 1995; 38(11): 1595–1603
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lang, R. Leflunomide. Clin. Immunother. 6, 306 (1996). https://doi.org/10.1007/BF03259092
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259092